The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

IRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

We are excited to work with Abbott to empower healthcare providers and people ... Tidepool+ will seamlessly merge data from ...

Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor.

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Abbott (NYSE: ABT) today released new data highlighting the emotional challenges faced by people living with type 2 diabetes, ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Tidepool collaborates with Abbott for seamless data integration ... Tidepool+ will seamlessly merge data from any sensor in the FreeStyle Libre portfolio into its Population Health Dashboard ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle ... Tidepool+ will seamlessly merge data from any sensor in the FreeStyle Libre portfolio into its Population Health ...

The iLet is the first insulin delivery system in the United States to connect to Abbott's FreeStyle Libre 3 Plus sensor, whose readings every minute will help the iLet calculate insulin doses.